相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data
Ruriko Koto et al.
MODERN RHEUMATOLOGY (2021)
Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data
Ruriko Koto et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)
2020 American College of Rheumatology Guideline for the Management of Gout
John D. FitzGerald et al.
ARTHRITIS CARE & RESEARCH (2020)
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
Atsushi Tanaka et al.
PLOS MEDICINE (2020)
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
A. Doria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Sunil V. Badve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
Sunao Kojima et al.
EUROPEAN HEART JOURNAL (2019)
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kenjiro Kimura et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study
Hisashi Yamanaka et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Treat-to-target (T2T) recommendations for gout
U. Kiltz et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Effects of Febuxostat in Early Gout A Randomized, Double-Blind, Placebo-Controlled Study
Nicola Dalbeth et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The Effects of Allopurinol on the Carotid Intima-media Thickness in Patients with Type 2 Diabetes and Asymptomatic Hyperuricemia: A Three-year Randomized Parallel-controlled Study
Peng Liu et al.
INTERNAL MEDICINE (2015)
Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis
Robert Jackson et al.
BMJ OPEN (2015)
Frequency and risk factors of gout flares in a large population-based cohort of incident gout
Dietrich Rothenbacher et al.
RHEUMATOLOGY (2011)
Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage
Shinya Kimura et al.
JOURNAL OF EPIDEMIOLOGY (2010)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)